| Financial Year |
March 31 2023 |
| Monetary Funds |
2,243,712,240.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
600,000.00 |
| Accounts Receivable |
506,562,527.28 |
| Advances to Suppliers |
38,870,781.83 |
| Other Receivables |
149,498,044.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
887,124,151.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
161,675,600.04 |
| Other Current Assets |
38,406,813.40 |
| Total Current Assets |
4,828,341,992.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
377,212,926.32 |
| Long-term Equity Investment |
94,454,485.77 |
| Investment Properties |
18,549,622.18 |
| Fixed Assetes |
292,347,395.15 |
| Under-construction Projects |
274,716.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
680,441,896.42 |
| R&D expenses |
220,692,350.43 |
| Goodwill |
922,278,909.99 |
| Long-Term Deferred and Prepaid Expenses |
19,595,284.88 |
| Deferred Income Tax Assets |
1,507,856.07 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,135,730,606.26 |
| Total Assets |
7,964,072,598.32 |
| Short-Term Loans |
2,339,935,106.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,670,923.90 |
| Accounts Payable |
402,229,683.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,068,575.92 |
| Taxes Payable |
78,940,325.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
91,419,078.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
227,524,443.64 |
| Other Current Liabilities |
87,689,399.36 |
| Sub-Total of Current Liabilities |
4,055,928,649.03 |
| Long-term Loans |
622,875,240.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,907,600.49 |
| Other Non-Current Liabilities |
44,420,464.66 |
| Sub-Total of Non-Current Liabilities |
772,920,408.99 |
| Total Liabilities |
4,828,849,058.02 |
| Paid-In Capital(Or Share Stock) |
1,443,191,991.00 |
| Capital Surplus |
3,903,069,446.94 |
| Surplus Reserve |
150,153,223.42 |
| LESS:Treasury Stock |
10,636,209.30 |
| Undistributed Profits |
-2,305,018,221.31 |
| Minority Stockholder's Interest |
-46,073,048.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,181,296,589.08 |
| Owner's Equity（Stockholder's Equity） |
3,135,223,540.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,964,072,598.32 |
